ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 154 filers reported holding ACCELERON PHARMA INC in Q1 2018. The put-call ratio across all filers is 3.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $178,000 | +27.1% | 1,036 | -7.1% | 0.00% | – |
Q2 2021 | $140,000 | -7.9% | 1,115 | -0.4% | 0.00% | -100.0% |
Q1 2021 | $152,000 | -5.0% | 1,120 | -10.6% | 0.00% | 0.0% |
Q4 2020 | $160,000 | +8.8% | 1,253 | -3.9% | 0.00% | 0.0% |
Q3 2020 | $147,000 | +26.7% | 1,304 | +7.1% | 0.00% | 0.0% |
Q2 2020 | $116,000 | -95.2% | 1,217 | -95.4% | 0.00% | -92.3% |
Q1 2020 | $2,396,000 | +60.3% | 26,660 | -5.5% | 0.01% | +116.7% |
Q4 2019 | $1,495,000 | +33.0% | 28,201 | -0.8% | 0.01% | +20.0% |
Q3 2019 | $1,124,000 | -4.4% | 28,439 | -0.7% | 0.01% | 0.0% |
Q2 2019 | $1,176,000 | -9.1% | 28,637 | +3.1% | 0.01% | 0.0% |
Q1 2019 | $1,294,000 | +16.6% | 27,783 | +9.1% | 0.01% | 0.0% |
Q4 2018 | $1,110,000 | -24.4% | 25,477 | -0.8% | 0.01% | 0.0% |
Q3 2018 | $1,469,000 | +20.1% | 25,672 | +1.8% | 0.01% | +25.0% |
Q2 2018 | $1,223,000 | +30.4% | 25,210 | +5.1% | 0.00% | +33.3% |
Q1 2018 | $938,000 | -12.6% | 23,997 | -5.1% | 0.00% | -25.0% |
Q4 2017 | $1,073,000 | +33.8% | 25,288 | +17.7% | 0.00% | +33.3% |
Q3 2017 | $802,000 | +32.8% | 21,487 | +8.1% | 0.00% | +50.0% |
Q2 2017 | $604,000 | +35.1% | 19,880 | +17.8% | 0.00% | 0.0% |
Q1 2017 | $447,000 | +11.2% | 16,878 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $402,000 | -99.9% | 15,759 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $571,838,000 | +6.7% | 15,801 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $536,102,000 | +59.6% | 15,777 | +24.1% | 0.00% | +100.0% |
Q1 2016 | $336,000,000 | -45.8% | 12,715 | 0.0% | 0.00% | -66.7% |
Q4 2015 | $620,000,000 | +195483.6% | 12,715 | -0.2% | 0.00% | +200.0% |
Q3 2015 | $317,000 | -99.9% | 12,737 | +0.1% | 0.00% | -50.0% |
Q2 2015 | $402,524,000 | +2.2% | 12,722 | +23.0% | 0.00% | 0.0% |
Q1 2015 | $393,693,000 | -2.3% | 10,344 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $403,002,000 | +23.9% | 10,344 | -3.8% | 0.00% | +100.0% |
Q3 2014 | $325,171,000 | -11.0% | 10,753 | -0.1% | 0.00% | -50.0% |
Q2 2014 | $365,517,000 | +142.2% | 10,760 | +145.9% | 0.00% | +100.0% |
Q1 2014 | $150,938,000 | -10.5% | 4,375 | +2.7% | 0.00% | 0.0% |
Q4 2013 | $168,656,000 | – | 4,259 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |